Where is the live CopyMark page for USPTO serial 79041407?

The live record is at https://getcopymark.com/trademark/79041407. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns Serial No. 79041407?

According to the public USPTO record for serial number 79041407, the listed owner(s) include: AstraZeneca AB, AstraZeneca AB, AstraZeneca AB.

What is USPTO serial number 79041407?

Serial number 79041407 is the USPTO application identifier for the mark Serial No. 79041407. It is used to track examination, publication, and registration of this trademark.

What is the current status of Serial No. 79041407?

Serial No. 79041407 (79041407) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover Serial No. 79041407?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: Serial No. 79041407 Serial# 79041407 | status 404; last event DENC | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79041407?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anesthesia, oncology, infection, inflammation, urology, gynecology; pharmaceutical preparations and substances for the treatment and prevention of diabetes	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Dec 22, 2017	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED	—
Dec 22, 2017	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Dec 14, 2017	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Aug 15, 2015	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Jul 28, 2015	INTS	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Jul 28, 2015	INPC	INVALIDATION PROCESSED	—
Apr 29, 2015	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Aug 29, 2014	C71T	CANCELLED SECTION 71	—
Jan 22, 2008	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 6, 2007	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 17, 2007	NPUB	NOTICE OF PUBLICATION	—
Oct 3, 2007	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Oct 2, 2007	ALIE	ASSIGNED TO LIE	—
Sep 1, 2007	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Sep 1, 2007	DOCK	ASSIGNED TO EXAMINER	—
Aug 31, 2007	NWAP	NEW APPLICATION ENTERED	—
Aug 30, 2007	LIMS	LIMITATION OF GOODS/SERVICES FROM IB ENTERED	—
Aug 30, 2007	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

Serial No. 79041407